Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$135,000.00
Apr 1, 2013
Targeting Androgen Receptor dimerization as a potential therapy for Prostate Cancer
$646,340.00
Apr 1, 2013
Effect of NPM mutation and NPM-MLF1 translocation on gene regulation
$548,527.00
Apr 1, 2013
Short bowel syndrome and glucagon-like peptide-2 therapy: actions and mechanisms studied in neonatal piglets
$644,094.00
Apr 1, 2013
T-box selector genes in Dorsal-Ventral leg development
$156,393.00
Apr 1, 2013
Injectable dense collagen-silk fibroin derived polypeptide hydrogels for bone regenerative therapy
$313,349.00
Apr 1, 2013
The role of IDO1 vs IDO2 on tumour immune evasion and immune therapy
$105,000.00
Apr 1, 2013
Elucidating the cell-type specific role of brain ATP-binding cassette A1 (ABCA1) in Alzheimer's disease and relevance to novel therapies.
$729,885.00
Apr 1, 2013
Mechanisms of response and resistance to epigenetic therapy in hematological malignancy
$651,061.00
Apr 1, 2013
Improving Quality and Patient Safety in Radiation Therapy by Integrating Multi-Disciplinary Criteria into an Artificial Intelligence System
$457,488.00
Apr 1, 2013
Discovery and Characterization of UROD Inhibitors for Cancer Therapy